Contact UsInvestorsCareersMediaContact Us
Investor Relations


SE Intimation- Meeting with Analyst Institutional Investor


Intimation - Appointment of Managing Director - Pfizer Limited

Stock Exchange Intimation - Interim Injunction on the prohibition of the manufacture and sale of the Corex -Pfizer Limited- March 14, 2016

Stock Exchange intimation-Prohibition on sale of drug Chlopheniramine Maleate + Codeine Syrup - March 14, 2016

Institutional Investors Meet Pfizer Limited

Intimation to Stock Exchanges – Analysts call - Results for the quarter ended December 31, 2015

Notice of Board Meeting – February 3, 2016

Appointment of Director – Ms. Lu Hong

Contact Details of the Authorized Key Managerial Personnel under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation to Stock Exchanges regarding Pfizer Inc. and Allergan Plc to combine

Pfizer Limited – Change of Registered Address

Notice of the Board Meeting – November 9, 2015

Resignation of Managing Director – Mr. Aijaz Tobaccowalla.Pfizer completes Acquisition of HospiraResignation of Executive Director – Dr. Lakshmi NadkarniWithdrawal of Thane Plant Closure Notice.Business Transfer Agreement with Vidhi Research and Development LLP for sale of Thane Plant.Pfizer Limited – 64th AGM evoting and poll resultsNotice of the Board Meeting – July 25, 2015Notice of the Board Meeting – May 5, 2015Intimation pursuant to Clause 30 of the Listing Agreement – February 14, 2015.Notice of the Board Meeting – February 14, 2015Pfizer Limited evoting results – 63th Annual General Meeting
About UsOur PeopleOur Community EffortsOur ProductsInvestorsCareerMediaAdverse Event ReportingHealth Care ProfessionalsTerms of UsePrivacy PolicyContact UsCopyright © 2002- 2021 Pfizer Inc. All rights reserved.